Invention Publication
- Patent Title: NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
-
Application No.: US17983501Application Date: 2022-11-09
-
Publication No.: US20230151019A1Publication Date: 2023-05-18
- Inventor: Hui Cao , Wei Li , Xuri Gao , Jiajun Zhang , Xiaowen Peng , Jorden Kass , Ruichao Shen , Guoqiang Wang , Yat Sun Or
- Applicant: ENANTA PHARMACEUTICALS, INC.
- Applicant Address: US MA Watertown
- Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Watertown
- Main IPC: C07D487/10
- IPC: C07D487/10 ; A61P31/14
Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof:
which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US11912714B2 Spiropyrrolidine derived antiviral agents Public/Granted day:2024-02-27
Information query
